Overview

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor

Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the addition of parathyroid hormone after a sequential cord blood transplant will improve engraftment, which is the ability of the transplanted stem cells to grow and to successfully begin producing new blood cells.
Phase:
Phase 2
Details
Lead Sponsor:
The Emmes Company, LLC
The EMMES Corporation
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Hormones
Parathyroid Hormone
Teriparatide